Skip to main content
Premium Trial:

Request an Annual Quote

VIB, NC State Form Strategic Alliance in Plant Biotech

NEW YORK (GenomeWeb) – Belgian life sciences institute VIB and North Carolina State University announced today that they have formed a strategic alliance in plant biotechnology research. 

Under the terms of the arrangement, the institutes will exchange investigators and form research collaborations in the areas of soil microbiomes, plant breeding, systems and synthetic biology, field phenotyping, and precision agriculture. They also intent to form new companies together.

"VIB has an excellent model for developing basic science discoveries that lead to startup companies, while we have a strong model for taking basic research and applying it to agricultural problems," Steve Lommel, associate dean of NC State's College of Agriculture and Life Sciences, said in a statement. "So we see this as a win-win relationship, one that will benefit both VIB and NC State, as well as the agriculture and agbiotech industries."

VIB Managing Director Johan Cardoen added that the collaboration "will open new research paths and will create new opportunities to boost the growth of both agbiotech clusters, which represent world-leading innovation clusters in plant science." 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.